ARTERIOSCLEROSIS AND DIABETES, A GLOBAL PROBLEM

OUR CONTRIBUTION AGAINST THE DISEASES NO. 1

EARLY DETECTION OF METABOLIC DISEASES

The onset of type 2 diabetes (T2D) can be seen as a worldwide epidemic. We provide quick tests for the early diagnosis of developing T2D. Our Latereal Flow Tests are designed to help doctors to diagnose a metabolic disease at an early stage and thus to facilitate medical screening. For us, prevention is a way to support a healthy, long life for all people.

Products used for early detection

The prevention of diseases is at least as important as the treatment. If, for example, a developing type 2 diabetes is diagnosed at an early stage, timely measures can lead to a reduction of the disease. Diabetes mellitus is almost always correlated with fatty liver disease. The liver plays a central role in fat metabolism. If this is disturbed, this can lead to elevated blood fat values and thus increase the risk of vascular calcification (arteriosclerosis). Our products are intended for physicians worldwide and in some cases for personal use.

Heilung

DEVELOPEMENT

The early diagnosis of metabolic diseases is a broad field that is directly related to the development of our new drug. Our team is working intensively on the development, manufacture and marketing of the drug for the effective reduction of arteriosclerotic plaque.